MedTrace Logo

Probiotics in Adults With Rheumatoid Arthritis

NCT07304505 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-12-31

No results posted yet for this study

Summary

The goal of this clinical study is to collect data on the effect of probiotic administration on clinical outcomes in rheumatoid arthritis patients.

Participants will:

* Have a 6-week daily administration of a probiotic
* Collect fecal samples every other day during the first 3 weeks of the study and twice weekly over the last 3 weeks
* Visit the clinic at Baseline, Week 3 and Week 6 for checkup and testing

Conditions

  • Rheumatoid Arthritis (RA)

Interventions

DIETARY_SUPPLEMENT

Align Extra Strength Probiotic Supplement

Bifidobacterium longum subsp. longum 35624™ (50mg): 5 x10\^9 (5 billion) live bacteria per capsule

Sponsors & Collaborators

  • Ancilia Biosciences

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-13
Primary Completion
2026-03-31
Completion
2026-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07304505 on ClinicalTrials.gov